ReviewFrontiers in immunology2026
Challenges in the standardization of innate immune status assessment.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The initial defense against pathogens is the innate immunity, which is characterized by rapidity and the broad-spectrum operation that facilitates the rapid identification and removal of the invasion by microorganisms. The determination of innate immune status is a methodological approach to assessing the strength of innate immune defense and has been extensively utilized in vaccine development, disease surveillance, clinical stratification, and postoperative recovery. Nevertheless, discrepancies in indicator purposes, methodologies, and references are currently seen where quantitative judgments cannot rely on and be consistent. Hence, methodological innovation and analysis technologies need to be developed, and a standardized approach and common criteria should be created to address the increasing clinical and research needs of quantitative assessment. In the framework of human health and clinical practice, the given work gives a concise review of the key inadequacies of current approaches to innate immune evaluation, incorporates the modifications into the current assessment criteria, explains the drawbacks of modern technologies, and suggests an evaluation scheme involving many parameters to facilitate the standardization and quantification of the assessment of the innate immune status.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.